Exsomi is a patent animal-derived extracellular microvesicle that activates the body’s natural ability to heal. We at Bioluga are dedicated to leveraging innovation and technology to make regenerative medicines effective and accessible to everyone, everywhere. We have promising data in several indications from studies done in our labs as well as in collaboration with other academic institutions.
Our strategic goal is to develop, manufacture and market novel drugs used in managing and treatment of many conditions. These include: